# SUBTHRESHOLD OPIOID USE DISORDER PREVENTION TRIAL (CTN-0101). DSC5 CONTRACT. 09/20/2019 - 11/16/2020. N01DA-19-2250.

> **NIH NIH N01** · THE EMMES COMPANY, LLC · 2022 · $245,168

## Abstract

SUBTHRESHOLD OPIOID USE DISORDER PREVENTION TRIAL (CTN-0101).

This study is part of the NIH’s Helping to End Addiction Long-term (HEAL) initiative to speed scientific solutions to the national opioid public health crisis. The NIH HEAL Initiative bolsters research across NIH to improve treatment for opioid misuse and addiction.

## Key facts

- **NIH application ID:** 10703337
- **Project number:** 75N95019D00013-P00003-759501900097-1
- **Recipient organization:** THE EMMES COMPANY, LLC
- **Principal Investigator:** PAUL VANVELDHUISEN
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $245,168
- **Award type:** —
- **Project period:** 2019-09-20 → 2023-08-16

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10703337

## Citation

> US National Institutes of Health, RePORTER application 10703337, SUBTHRESHOLD OPIOID USE DISORDER PREVENTION TRIAL (CTN-0101). DSC5 CONTRACT. 09/20/2019 - 11/16/2020. N01DA-19-2250. (75N95019D00013-P00003-759501900097-1). Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/grant/nih/10703337. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*